Science Explorer Back to mapMap

Most cited papers from Arena Pharmaceuticals (United States)

What are the most cited papers from Arena Pharmaceuticals (United States)?

The most cited paper from Arena Pharmaceuticals (United States) is "Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group" (Claudio Vitali, S Bombardieri, R Jonsson et al., 2002), with 5,366 citations. Next come "Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management" (912) and "A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)" (722).

Showing 50 of 60 papers. Every paper with more than 74 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Claudio Vitali, S Bombardieri, R Jonsson et al. · Annals of the Rheumatic Diseases Open access Jun 2002 5,366
2 Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management Steven R. Smith, Neil J. Weissman, Christen M. Anderson et al. · New England Journal of Medicine Open access 14 Jul 2010 912
3 A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II) Caroline M. Apovian, Louis J. Aronne, Domenica Rubino et al. · Obesity Open access 14 Feb 2013 722
4 Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression Juan F. López, Derek T. Chalmers, Karley Y. Little et al. · Biological Psychiatry Apr 1998 703
5 (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G Andrew K.P. Taggart, Jukka Kero, Xiaodong Gan et al. · Journal of Biological Chemistry Open access Jun 2005 660
6 Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1 Michael W. Melkus, Jacob D. Estes, Angela Padgett‐Thomas et al. · Nature Medicine 22 Oct 2006 660
7 GPR41/FFAR3 and GPR43/FFAR2 as Cosensors for Short-Chain Fatty Acids in Enteroendocrine Cells vs FFAR3 in Enteric Neurons and FFAR2 in Enteric Leukocytes Mark Klitgaard Nøhr, Maria H. Pedersen, Andreas Gille et al. · Endocrinology 25 Jul 2013 596
8 A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial Meredith C. Fidler, Matilde Sanchez, Brian Raether et al. · The Journal of Clinical Endocrinology & Metabolism 27 Jul 2011 561
9 Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study Patrick Mahlen O'Neil, Steven R. Smith, Neil J. Weissman et al. · Obesity 16 Mar 2012 530
10 Tyro-3 family receptors are essential regulators of mammalian spermatogenesis Qingxian Lu, Martin Gore, Qing Zhang et al. · Nature Apr 1999 516
11 2016 Focused Update: Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations Marco Guazzi, Ross A Arena, Martin Halle et al. · Circulation Open access 2 May 2016 456
12 Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization William J. Thomsen, Andrew J. Grottick, Frederique Menzaghi et al. · Journal of Pharmacology and Experimental Therapeutics 6 Feb 2008 405
13 A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release Zhi‐Liang Chu, Christopher J. Carroll, Jean Alfonso et al. · Endocrinology 17 Jan 2008 387
14 Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies William J. Sandborn, Severine A.R.A. Vermeire, Laurent Peyrin‐Biroulet et al. · The Lancet Open access 2 Mar 2023 363
15 Marine Protected Areas: Tools for Sustaining Ocean Ecosystems Peter H. Flournoy · Journal of International Wildlife Law & Policy 2003 357
16 A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers Maria Waldhoer, Jamie C Fong, Robert M. Jones et al. · Proceedings of the National Academy of Sciences Open access 2 Jun 2005 344
17 Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells Maja Storm Engelstoft et al. · Molecular Metabolism Open access 3 Sep 2013 325
18 Arcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food Intake Darleen A. Sandoval, Didier Bagnol, Stephen C. Woods et al. · Diabetes Open access 16 May 2008 324
19 Role of GPR81 in lactate-mediated reduction of adipose lipolysis Tian‐Quan Cai, Ning Ren, Lan Jin et al. · Biochemical and Biophysical Research Communications 25 Oct 2008 308
20 A Role for β-Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucose-Dependent Insulin Release Zhi‐Liang Chu, Robert M. Jones, Hongmei He et al. · Endocrinology 9 Feb 2007 295
21 Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis William J. Sandborn, Laurent Peyrin‐Biroulet, Jinkun Zhang et al. · Gastroenterology Open access 8 Nov 2019 236
22 Functional assays for screening GPCR targets William J. Thomsen, John M. Frazer, David J. Unett · Current Opinion in Biotechnology Review 21 Nov 2005 224
23 International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B) Stefan Offermanns, Steven L. Colletti, Timothy W. Lovenberg et al. · Pharmacological Reviews Open access 26 Apr 2011 205
24 Discovery and Structure−Activity Relationship of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a Selective Serotonin 5-HT2C Receptor Agonist for the Treatment of Obesity Brian M. Smith et al. · Journal of Medicinal Chemistry Open access 21 Dec 2007 202
25 CaMKIIδ Isoforms Differentially Affect Calcium Handling but Similarly Regulate HDAC/MEF2 Transcriptional Responses Tong Zhang, Michael Kohlhaas, Johannes Backs et al. · Journal of Biological Chemistry Open access 9 Oct 2007 202
26 Lorcaserin (APD356), a Selective 5‐HT2CAgonist, Reduces Body Weight in Obese Men and Women Steven R. Smith, Warren A. Prosser, David J. Donahue et al. · Obesity 4 Dec 2008 191
27 Langerhans Cells Release Prostaglandin D2 in Response to Nicotinic Acid Dominique Maciejewski-Lenoir, Jeremy G. Richman, Yaron Hakak et al. · Journal of Investigative Dermatology Open access 28 Sep 2006 190
28 Salting-Out Assisted Liquid–Liquid Extraction for Bioanalysis Yong Q. Tang, Naidong Weng · Bioanalysis Jun 2013 177
29 GPR119 agonists for the treatment of type 2 diabetes Robert M Jones, James N. Leonard, Daniel J. Buzard et al. · Expert Opinion on Therapeutic Patents 28 Sep 2009 156
30 Modulation of sphingosine-1-phosphate in inflammatory bowel disease Laurent Peyrin‐Biroulet, Ronald J. Christopher, Dominic P. Behan et al. · Autoimmunity Reviews 7 Mar 2017 155
31 Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119 Graeme Semple, Beatriz Fioravanti, Guilherme Rocha Pereira et al. · Journal of Medicinal Chemistry Open access 13 Aug 2008 143
32 Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies Serre-Yu Wong et al. · Gastroenterology Open access 20 Apr 2021 141
33 Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists Sangdon Han, Jayant Thatte, Daniel J. Buzard et al. · Journal of Medicinal Chemistry Open access 18 Jul 2013 134
34 Lorcaserin, A 5-HT2CReceptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure Corby K. Martin, Leanne Maree Redman, Jinkun Zhang et al. · The Journal of Clinical Endocrinology & Metabolism Open access 29 Dec 2010 134
35 Mindfulness-based training attenuates insula response to an aversive interoceptive challenge Lori Haase, Nate J. Thom, Akanksha Shukla et al. · Social Cognitive and Affective Neuroscience Open access 8 Apr 2014 128
36 N-Oleoyldopamine Enhances Glucose Homeostasis through the Activation of GPR119 Zhi‐Liang Chu, Christopher J. Carroll, Ruoping Chen et al. · Molecular Endocrinology Open access 10 Nov 2009 127
37 Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression Brett P. Lauring et al. · Science Translational Medicine 22 Aug 2012 127
38 The effect of vitamin D on renin–angiotensin system activation and blood pressure Ciaran J. McMullan, Lea Borgi, Gary C. Curhan et al. · Journal of Hypertension Open access 30 Dec 2016 126
39 Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure Que Liu, Christen M. Anderson, Anatoly Broyde et al. · Cardiovascular Diabetology Open access 16 Nov 2010 124
40 Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy James W. Wheless, Dennis Dlugos, Ian Miller et al. · CNS Drugs Open access 2 May 2019 114
41 Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study Severine A.R.A. Vermeire, Michael V. Chiorean, Julián Panés et al. · Journal of Crohn s and Colitis Open access 19 Jan 2021 109
42 The use of constitutively active GPCRs in drug discovery and functional genomics Derek T. Chalmers, Dominic P. Behan · Nature Reviews Drug Discovery Review Aug 2002 109
43 A double dissociation between serial reaction time and radial maze performance in rats subjected to 192 IgG‐saporin lesions of the nucleus basalis and/or the septal region Olivia Lehmann, Andrew J. Grottick, J. ‐C. Cassel et al. · European Journal of Neuroscience Open access Aug 2003 103
44 Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone Roberto Ciccocioppo, Daniel C.-H. Lin, Rémi Martin‐Fardon et al. · Psychopharmacology 27 Mar 2003 102
45 GCR1 , the putative Arabidopsis G protein-coupled receptor gene is cell cycle-regulated, and its overexpression abolishes seed dormancy and shortens time to flowering Gabriella Colucci, Fabio Apone, Nicole Alyeshmerni et al. · Proceedings of the National Academy of Sciences Open access 2 Apr 2002 102
46 Regulation of 5‐HT Receptors and the Hypothalamic‐Pituitary‐Adrenal Axis Juan F. López, Delia M. Vázquez, Derek T. Chalmers et al. · Annals of the New York Academy of Sciences Open access Dec 1997 100
47 3-(1 H -Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice Graeme Semple et al. · Journal of Medicinal Chemistry Open access 30 Jul 2008 99
48 Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors Jeremy G. Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov et al. · Journal of Biological Chemistry Open access 24 Apr 2007 99
49 Global analysis of G‐protein‐coupled receptor signaling in human tissues Yaron Hakak, Devin Shrestha, Moira C. Goegel et al. · FEBS Letters Open access 30 Jul 2003 95
50 Glabellar Contraction Patterns: A Tool to Optimize Botulinum Toxin Treatment Ada Regina Trindade de Almeida, Elisa Raquel Martins da Costa Marques, Raul A. Banegas et al. · Dermatologic Surgery 17 Jul 2012 91

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.